Foxchart.com
Axcella Health Inc. (AXLA)
4.58  0 (0%)  01-16 16:00
Open: 0.36
High: 4.58
Low: 0.36
Volume: 6,782
Market Cap: 13(M)
PE Ratio: -0.25
Exchange: NASDAQ Global Market
Industry: Biotechnology
Sector: Healthcare
Technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell buy
Resistance 2: 4.10
Resistance 1: 2.66
Pivot price: 0.67
Support 1: 0.34
Support 2: 0.28
52w High: 4.58
52w Low: 0.36
Watchlist
AXLA0 (0%)
SEAS0 (0%)
PINS0 (0%)
DMB0 (0%)
FDG0 (0%)
AFT0 (0%)
Zoom in Zoom out
Draw lines
Horizontal lines
Parallel lines
Fibonacci lines
Remove studies
Shot and share

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Financials
EPS -41300000.000
Book Value 0.000
PEG Ratio 0.00
Gross Profit 0.000
Profit Margin (%) 0.00
Operating Margin (%) 0.00
Return on Assets (ttm) -87.7
Return on Equity (ttm) -1.0
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
×
Share on Facebook Tweet this page

Foxchart international:  |  United States  |  Canada  |  United Kingdom  |  Australia  |  New Zealand  |  Singapore  |  India

©Foxchart.com All Rights Reserved. Foxchart.com | United States NYSE NASDAQ AMEX stock markets, stock quotes and stock technical analysis charts. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither Foxchart.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX